Ambrosia Biotherapeutics (Stealth)

👥 1 employees💰 Last funded Aug 2025
We’re pioneering a new class of therapies that restore natural tolerance instead of suppressing the immune system. A new class of therapies that could cure autoimmune disease, forever.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Ambrosia Biotherapeutics (Stealth)?
Ambrosia Biotherapeutics (Stealth) has 1 investor on record on gritt.io.
When did Ambrosia Biotherapeutics (Stealth) last raise funding?
The most recent investment in Ambrosia Biotherapeutics (Stealth) recorded on gritt.io was in August 2025.
What industry is Ambrosia Biotherapeutics (Stealth) in?
Ambrosia Biotherapeutics (Stealth) operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.